Table 5. Examples of characteristic clinical findings in LE subtypes.
(Table adapted from Lancaster, 2016 [70])
NMDA-R = N-methyl-D-aspartate receptor, AMPAR = α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, GABA-Br = gamma-amino butyric acid receptor type B, LGI1 = leucine-rich, glioma inactivated, CASPR2 = contactin-associated protein-like 2, GAD = glutamic acid decarboxylase
| Clinical finding | Associated Antibody Subtype |
| Psychotic symptoms | NMDA-R, AMPAR, GABA-BR |
| Movement disorders | NMDA-R |
| Status epilepticus | GABA-BR (more characteristics) NMDA-R (more common) |
| Fasciobrachial dystonic seizures | LGI-1 (precedes diagnosis) |
| Peripheral motor hyperexcitability | CASPR2 (more common) > LGI1 |
| Stiff-person syndrome | GAD65 |
| Cranial neuropathies | Ma2, Hu |
| Cerebellitis | GAD65 |